+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?

Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?

European Journal of Internal Medicine 26(4): 268-272

Adherence to statin therapy has been shown to be suboptimal. In statin-treated patients with residual elevated low density lipoprotein cholesterol (LDL-C) levels the physician must decide whether to switch to a more potent statin or try and achieve better adherence. We examined the association between adherence and LDL-C within low, moderate and high intensity statin groups in a "real world" setting. We assessed annual adherence by the mean MPR (Medication Possession Ratio = number of purchased/prescribed daily doses) in unselected patient group. Statins were stratified (ACC/AHA Guideline) into low, moderate and high intensity groups. The impact of adherence on LDL levels was assessed by LOESS (locally weighted scatter plot smoothing). Out of 1183 patients 173 (14.6%) were treated with low, 923 (78.0%) with moderate and 87 (7.4%) with high intensity statins. Statin intensity was inversely associated with adherence (MPR 77±21, 73±22 and 69±21% for low, moderate and high intensity respectively, p=0.018). Non-adjusted LDL levels decreased with higher adherence: a 10% adherence increase resulted in LDL decrease of 3.5, 5.8 and 7.1mg/dL in low, moderate and high intensity groups. Analysis of the adherence effect on LDL levels adjusted for age, DM and ischemic heart disease showed that MPR above 80% was associated with an additional decrease in LDL levels only in the high intensity group. Increased adherence to statins beyond an MPR of 80% improves LDL levels only among patients given high intensity therapy. Switching from lower to higher intensity therapy may be more effective than further efforts to increase adherence.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058900362

Download citation: RISBibTeXText

PMID: 25770073

DOI: 10.1016/j.ejim.2015.02.014

Related references

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. American Journal of Cardiology 114(6): 826-831, 2014

It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality. Journal of the American Heart Association 8(7): E011378, 2019

Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. Journal of Personalized Medicine 4(2): 147-162, 2014

Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology 37(11): 653-659, 2015

Impact of prescription size on statin adherence and cholesterol levels. Bmc Health Services Research 7: 175, 2007

Significant improvement in statin adherence and cholesterol levels after acute myocardial infarction. Danish Medical Journal 59(9): A4509, 2012

Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial). American Journal of Cardiology 120(6): 893-897, 2017

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence. Cardiovascular Research 114(8): 1073-1081, 2018

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk. Plos one 13(2): E0191817, 2018

Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study. Bmc Geriatrics 19(1): 41, 2019

Achievement of LDL Cholesterol Goal and Adherence to Statin by Diabetes Patients in Kelantan. Malaysian Journal of Medical Sciences 24(3): 44-50, 2017

Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology 66(8): 1164-1170, 2006

Associations between patients' adherence and GPs' attitudes towards risk, statin therapy and management of non-adherence--a survey and register-based study. Family Practice 33(2): 140-147, 2016

Association between statin adherence and cholesterol level reduction from baseline in a veteran population. PharmacoTherapy 33(10): 1044-1052, 2013